Ge Long Hui A P P·2026-01-12 11:26Group 1 - The core point of the article is that *ST Jingfeng (000908.SZ) has announced a restructuring plan that involves a capital increase through the conversion of capital reserves into shares [1] - The restructuring plan will use the existing share capital of 879,774,351 shares as a base, with a proposed conversion ratio of 10 shares for every 10 shares, resulting in a total of 879,774,351 additional shares to be issued [1] - After the conversion, the total share capital of Jingfeng Pharmaceutical will increase to 1,759,548,702 shares, with the final number of shares subject to confirmation by the Shenzhen branch of China Securities Depository and Clearing Corporation [1] Group 2 - The newly issued shares will not be distributed to existing shareholders but will be used to attract restructuring investors, who will provide funds for subscription [1] - The funds raised will be utilized to cover bankruptcy costs, settle various debts, and replenish the company's working capital as outlined in the restructuring plan [1]